Hanger, Inc., a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced the launch of Hanger Ventures, a subsidiary designed to focus on accelerating innovation, developing technology, and improving patient outcomes worldwide. Using robust clinical expertise and scale, Hanger Ventures will invest in entrepreneurs and small businesses, helping to bring innovative O&P healthcare solutions to the market.
“Hanger Ventures will enable us to provide resources typically not accessible to entrepreneurs and small businesses, collaborating from incubation to commercialization,” shared Hanger Chief Executive Officer (CEO) Pete Stoy. “This type of collaboration enables us to be at the forefront of innovation, with involvement in research and development centered around patient outcomes, ultimately providing more access and better care across the O&P community.”
Also Read : Health Catalyst Names UnityPoint Health Winner of the 2024 Flywheel Award
Hanger’s Chief Clinical Officer James Campbell, Ph.D., who leads the Hanger Institute and Clinical and Scientific Affairs division, will now also serve as President of Hanger Ventures. Dr. Campbell has 40 years of experience in the O&P profession with distinction in leadership and research, and is a named inventor on five issued U.S. Patents.
“Dr. Campbell is uniquely qualified to lead Hanger Ventures, leveraging his expertise, the work of the Hanger Institute, and our nationwide outcomes data to move the entire practice of O&P forward,” shared Stoy.
“Only at Hanger are we positioned to collaborate in this capacity,” shared Dr. Campbell. “Hanger Ventures marks another significant step in our desire to transform O&P while creating value for our partners throughout the care continuum.”
SOURCE : BusinessWire